Corona Vaccine For Children, March 17: Moderna, the biotechnology company, announced that it has begun trials to test its anti-corona virus vaccine on young children.
The company added in a statement, according to the Business Insider website, that the first participants in a study conducted on children between the ages of 6 months and 12 years received doses of the Corona vaccine, adding that it cooperated with the National Institutes of Health and the Advanced Biomedical Research and Development Authority in the study.
The company plans to enroll 6,750 participants in the United States and Canada for the trial, called the KidCOVE study, in which researchers will assess the safety of the two-dose vaccine at a 28-day interval.
The United States has not yet approved the use of the Corona vaccine for people under the age of 16 years, as researchers have prioritized adults in initial vaccine trials, since serious complications of the virus are rare in children.
Clinical trials in children differ from those in adults, due to the increased layers of protection, and both parents and children must agree to participate. Immunity systems also differ depending on the child’s age, which leads to more complex trials compared to studies of adults.
Moderna CEO Stefan Bansel said in a statement: “This study of children will help us evaluate the potential safety and effectiveness of our anti-Corona vaccine in this younger age group.”
And America’s chief epidemiologist, Anthony Fauci, said that vaccinating children is critical to reaching community immunity, expecting children to start receiving Corona vaccines, by the time the school starts in September.